Prevent CINV for up to 5 days with a single dose of AKYNZEO® given with dexamethasone The first and only 5-HT3 and NK-1 combination agent approved for both acute and delayed CINV1,2

View AKYNZEO clinical trial data in:

*The efficacy of AKNYZEO for injection for the prevention of CINV has not been established in a clinical study of patients treated with AC chemotherapy.